Improved Antibacterial Activity of 1,3,4-Oxadiazole-Based Compounds That Restrict Staphylococcus aureus Growth Independent of LtaS Function
ACS Infectious Diseases · 2023
DOI: 10.1021/acsinfecdis.3c00250 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, 2023. Verfasst von Edward J A Douglas und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, University of Bath, Bath BA2 7AY, U.K. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Department of Health, Medical Research Council Centre for Medical Mycology.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Sciences, University of Bath, Bath BA2 7AY, U.K.
- School of Chemistry, Cardiff University, Cardiff CF10 3AT, Wales, U.K.
- Medical Research Council Centre for Medical Mycology at the University of Exeter, University of Exeter, Exeter EX4 4DQ, U.K.
- Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina I-98125, Italy.
ORCID-Profile: Seána Duggan, Serena Vittorio, Michaela Serpi, Maisem Laabei
Förderung
- Medical Research Council
- Department of Health
- Medical Research Council Centre for Medical Mycology
- Microbiology Society
- Academy of Medical Sciences
- National Institute for Health and Care Research
- University of Exeter
- University of Bath
Zitieren
APA
Douglas, E. J. A., Marshall, B., Alghamadi, A., Joseph, E. A., Duggan, S., Vittorio, S., De Luca, L., Serpi, M., & Laabei, M. (2023). Improved Antibacterial Activity of 1,3,4-Oxadiazole-Based Compounds That Restrict Staphylococcus aureus Growth Independent of LtaS Function. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.3c00250
Vancouver
Douglas EJA, Marshall B, Alghamadi A, Joseph EA, Duggan S, Vittorio S, et al. Improved Antibacterial Activity of 1,3,4-Oxadiazole-Based Compounds That Restrict Staphylococcus aureus Growth Independent of LtaS Function. ACS Infectious Diseases. 2023. doi:10.1021/acsinfecdis.3c00250
BibTeX
@article{Douglas2023,
author = {Douglas, Edward J A and Marshall, Brandon and Alghamadi, Arwa and Joseph, Erin A and Duggan, Seána and Vittorio, Serena and De Luca, Laura and Serpi, Michaela and Laabei, Maisem},
title = {Improved Antibacterial Activity of 1,3,4-Oxadiazole-Based Compounds That Restrict Staphylococcus aureus Growth Independent of LtaS Function},
journal = {ACS Infectious Diseases},
year = {2023},
doi = {10.1021/acsinfecdis.3c00250}
}
EUVIMED